NMVA.F · Captor Capital Corp

-

Please sign in to comment on NMVA.F

1 Comment

Admin

4 years ago

Captor Capital Corp is currently in a long term uptrend where the price is trading 87.4% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.

Captor Capital Corp's total revenue rose by 99.0% to $4M since the same quarter in the previous year.

Its net income has increased by 92.4% to $-825K since the same quarter in the previous year.

Finally, its free cash flow grew by 42.8% to $-2M since the same quarter in the previous year.

Based on the above factors, Captor Capital Corp gets an overall score of 5/5.

Exchange	F
CurrencyCode	EUR
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
ISIN	CA14075H2028

PE Ratio	None
Target Price	None
Dividend Yield	0.0%
Market Cap	16M
Beta	0.36

ABOUT

Captor Capital Corp

Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. The company owns and operates a retail chain of nine dispensaries in California, including Santa Cruz, Antioch, El Sobrante, Salinas, Lompoc, Goleta, Atwater, Palm Springs, and Castroville under the One Plant brand name. It also operates an e-commerce site under One Plant brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2, 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.

NMVA.F · Captor Capital Corp

-

Captor Capital Corp

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Captor Capital Corp using a moving average strategy